Andtbacka RH, Ross M, Agarwala SS, et al. A phase II multicentre trial of HF10, oncolytic virus immunotherapy, and ipilimumab combination treatment in patients with stage IIIB-IV unresectable or metastatic melanoma. SMR 2017, abstract SMR04-2.
Versnelde FDA-goedkeuring lifileucel (Amtagvi) voor melanoom
mrt 2024 | Dermato-oncologie, Immuuntherapie